MTOR and Merkel cell skin cancer: Together, MCV-positive and MCV-negative cancers may have shared abnormalities in oncogenic signaling though the underlying mechanisms are not fully understood, and targeting mTOR pathway may be therapeutic in MCC regardless of MCV status [40, 65, 66].